Nano‐plastics disrupt systemic metabolism by remodeling the bile acid–microbiota axis and driving hepatic–intestinal dysfunction

Documenti analoghi

• A gut microbiota‐bile acid axis inhibits the infection of an emerging coronavirus by targeting its cellular receptor aminopeptidase N
  di: Ya‐Qing Zhang, et al.
  Pubblicazione: (2025)
• HLF and PPARα axis regulates metabolic‐associated fatty liver disease through extracellular vesicles derived from the intestinal microbiota
  di: Xingzhen Yang, et al.
  Pubblicazione: (2025)
• Cross‐tissue multi‐omics analyses reveal the gut microbiota's absence impacts organ morphology, immune homeostasis, bile acid and lipid metabolism
  di: Juan Shen, et al.
  Pubblicazione: (2025)
• Antioxidants promote metabolic remodeling in cattle rumen epithelium revealed by single‐cell resolution
  di: Sen‐Lin Zhu, et al.
  Pubblicazione: (2025)
• Cardiovascular disease therapeutics via engineered oral microbiota: Applications and perspective
  di: Wenyu Zhen, et al.
  Pubblicazione: (2024)